ProfileJobs

STERIS

Healthpharma

STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.

Revenue(FY, 2017)
$2.6 B
Market capitalization(2017-09-22)
$7.4 B
Company Growth (employees)
Type
Public
HQ
Mentor, US
Founded
1987
Size (employees)
12,000 (est)-14%
Website
steris.com
STERIS was founded in 1987 and is headquartered in Mentor, US

STERIS Office Locations

STERIS has an office in Mentor
Mentor, US (HQ)
5960 Heisley Rd
Mentor, US
9260 Progress Pkwy

STERIS Data and Metrics

STERIS Financial Metrics

STERIS's revenue was reported to be $2.6 b in FY, 2017 which is a 17% increase from the previous period.
USD

Revenue (FY, 2017)

2.6 b

Revenue growth (FY, 2016 - FY, 2017), %

17%

Gross profit (FY, 2017)

1 b

Gross profit margin (FY, 2017), %

39%

Net income (FY, 2017)

110 m

EBIT (FY, 2017)

227.6 m

Market capitalization (22-Sep-2017)

7.4 b

Cash (31-Mar-2017)

282.9 m
STERIS's current market capitalization is $7.4 b.
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.6 b1.9 b2.2 b2.6 b

Revenue growth, %

14%21%17%

Cost of goods sold

972.6 m1.1 b1.3 b1.6 b

Gross profit

649.6 m774.3 m895.5 m1 b
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

618.7 m638.4 m646.4 m646.8 m

Cost of goods sold

380.5 m398.4 m398.5 m389.2 m

Gross profit

238.2 m240 m247.9 m257.6 m

Gross profit Margin, %

38%38%38%40%
show all
USDFY, 2014FY, 2015FY, 2016FY, 2017

Cash

152.8 m167.7 m248.8 m282.9 m

Accounts Receivable

313.7 m325.3 m471.5 m483.5 m

Inventories

37 m35 m59.4 m197.8 m

Current Assets

674.7 m720.4 m972.5 m1 b
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

231.4 m242.4 m254.4 m264.9 m

Accounts Receivable

440.9 m439.8 m441.3 m443.7 m

Inventories

208.3 m209.6 m209.9 m209.7 m

Current Assets

965.7 m945.9 m956.2 m970.3 m
show all
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

129.4 m135.1 m110.8 m110 m

Accounts Receivable

(29 m)(2.8 m)(31.6 m)(48.1 m)

Accounts Payable

19.4 m(3.1 m)5.2 m6.9 m

Cash From Operating Activities

209.6 m246 m81.2 m424.1 m
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

20 m48.4 m88.9 m84.6 m

Accounts Receivable

(3.1 m)23.2 m11.7 m(213 k)

Accounts Payable

(17.9 m)(13.2 m)(17 m)(5.8 m)

Cash From Operating Activities

104.6 m80.3 m188.5 m289.4 m
show all
USDY, 2017

Revenue/Employee

201 k

Financial Leverage

1.8 x
Show all financial metrics

STERIS Operating Metrics

FY, 2016

Patents (foreign)

1.1 k

Patents (US)

390

Patents Pending

470
Show all operating metrics

STERIS Market Value History

STERIS Revenue Breakdown

STERIS Median Salaries

Source: 46 public H-1B filings from STERIS

Market Position of STERIS

Competitors

Horizon Pharma
Health - Public
BioDelivery Sciences International
Health - Public
Perrigo
Health - Public
Valeant Pharmaceuticals International
Health - Public
Compare competitors

Traffic Overview of STERIS

STERIS Online and Social Media Presence

STERIS Company Life and Culture

You may also be interested in